LIF production can be regulated by many different factors such as interleukins under different conditions in different tissue/cell types [49] and it has been investigated also in relation to Multiple sclerosis (MS) as a potential therapeutic factor [50] and to neuroinflammatory lesions [51]. This evidence concerns the gene LIF and multiple sclerosis.